Edition:
United Kingdom

Carl O'Donnell

Missouri appeals court overturns $110 million Johnson & Johnson talc verdict

16 Oct 2019

NEW YORK A Missouri appeals court overturned a $110 million verdict against Johnson & Johnson in a lawsuit by a Virginia woman who says she developed ovarian cancer after decades of using of its talc-based products for feminine hygiene.

Trump administration to announce changes to anti-kickback rules for healthcare providers

10 Oct 2019

The Trump administration will announce plans to change healthcare regulations on Wednesday to loosen anti-kickback provisions that restrict the kinds of outside services providers can refer patients to, administration officials said.

Massive jury award against J&J highlights risks of its legal strategy

09 Oct 2019

A jury award that hit Johnson & Johnson with $8 billion in punitive damages for a case involving its anti-psychotic drug Risperdal highlights the risks of the drugmaker's all-or-nothing legal strategy, several legal experts told Reuters on Wednesday. | Video

UPDATE 1-Trump administration proposes changes to anti-kickback rules for healthcare

09 Oct 2019

Oct 9 The Trump administration on Wednesday proposed changes to federal anti-kickback provisions that restrict the kinds of patient referrals doctors can make, saying it will improve healthcare coordination and foster payments based on the quality of care.

MOVES-Credit Suisse bolsters life sciences banking team -memo

05 Sep 2019

Sept 5 Credit Suisse Group AG has brought on three new senior investment bankers as it continues to build out its healthcare investment banking division, according to an internal memo reviewed by Reuters.

Trump administration to appeal ruling blocking price disclosure for drug ads

22 Aug 2019

The Trump administration is appealing a court ruling that struck down its plan to compel pharmaceutical companies to disclose wholesale prices of their drugs in televisions advertisements.

Pfizer invests $500 million in expanding gene therapy facility

21 Aug 2019

Pfizer Inc is investing $500 million to expand a manufacturing facility in Sanford, North Carolina, that plays a central role in its efforts to become a major player in gene therapy, the company said on Wednesday.

Buyout firm Centerbridge makes major investment in GoHealth

19 Aug 2019

Aug 19 Private equity firm Centerbridge Partners LP has made a significant investment in GoHealth LLC, giving the online health insurance marketplace a major new financial backer at a time when the insurance industry is bracing for change.

Buyout firm Centerbridge nears $1.5 bln deal for GoHealth -sources

19 Aug 2019

Aug 18 Private equity firm Centerbridge Partners LP is nearing a deal to acquire a majority stake in GoHealth LLC that could value the U.S. online health insurance marketplace at about $1.5 billion, people familiar with the matter said on Sunday.

Mylan deal puts future of its beleaguered EpiPen in spotlight

29 Jul 2019

Mylan NV's planned merger with Pfizer Inc's off-patent branded drugs business may have boosted its share price on Monday, but one of its most pressing problems remains: shortages of its flagship EpiPen emergency allergy treatment.

World News